Core Viewpoint - The company is committed to enhancing shareholder value through potential stock buybacks and effective market value management in response to recent regulatory support for such actions [1] Group 1: Stock Buyback and Market Value Management - The company will disclose any stock buyback plans after obtaining necessary approvals from the board and shareholders [1] - The company emphasizes sustainable development and long-term shareholder interests as part of its core strategy for market value management [1] - The company has implemented a "Market Value Management Measures" and is committed to annual cash dividends during profitable years to enhance investor returns [1]

General Overview - The company aims to enhance its ESG performance and core competitiveness through strategic development and investment decision-making processes [1][2] - The Strategic and Development Committee is established under the board of directors to research and propose suggestions on long-term development strategies, major investment decisions, and ESG governance [1][2] Committee Composition - The Strategic and Development Committee consists of three directors appointed by the board [3] - The chairman of the committee is the company’s chairman, responsible for convening and presiding over committee meetings [3][4] Responsibilities and Authority - The committee's main responsibilities include researching and proposing suggestions on long-term development strategies, major investments, capital operations, and significant ESG matters [2][4] - The committee is also tasked with evaluating and supervising the implementation of these matters and reporting to the board [2][4] Meeting Procedures - The committee is required to hold at least one regular meeting annually, with additional meetings convened as necessary [4][5] - Meetings can be conducted in person or through other means, ensuring all members can express their opinions [4][5] Voting and Documentation - A quorum of two-thirds of the committee members is required for meetings to proceed, and decisions must be approved by a majority [5] - Meeting records must be kept for at least ten years, and confidentiality regarding meeting discussions is mandatory for all participants [5]

Industry Overview - The global energy structure is rapidly transforming under the influence of "dual carbon" goals, with the energy storage industry reshaping the energy system at an astonishing pace [1] - According to IRENA, global renewable energy installed capacity is expected to exceed 4448 GW in 2024, with new energy storage installations reaching 165.4 GW, a year-on-year increase of 81.1%, representing a significant portion of the global energy storage market [1] - BloombergNEF predicts that in 2025, global energy storage additions will reach 86 GW/221 GWh, with China, the US, and Europe contributing over 90% of the growth, while emerging markets like Saudi Arabia and South Africa are growing at an annual rate exceeding 50% [1] Company Initiatives - Haicheng Energy Storage showcased its innovative products at the Abu Dhabi World Future Energy Summit, reflecting its commitment to sustainable development and continuous efforts in the energy storage sector [3] - The company is actively promoting green manufacturing by establishing a green supply chain system and information platform, integrating green concepts throughout the product lifecycle from design to recycling [5] - In factory construction, Haicheng has formed special teams to optimize resource utilization and reduce energy consumption, transitioning to efficient, low-carbon, and environmentally friendly production models [6] ESG Practices - Haicheng Energy Storage has developed a comprehensive ESG governance system, addressing 24 key issues and enhancing communication with various stakeholders [8] - The company launched the HeroEE home power solution to address energy poverty, supporting local infrastructure development and contributing to the UN's Sustainable Development Goal 7 [8] - Haicheng has created a carbon digital management platform to assist in carbon reduction, accurately calculating carbon emissions throughout the product lifecycle and supporting the entire supply chain in reducing carbon footprints [8] Achievements and Recognition - In 2024, Haicheng was recognized as a "Green Supply Chain Management Enterprise" and "Green Factory" by the Ministry of Industry and Information Technology, and received accolades as a "National Supply Chain Innovation and Application Demonstration Enterprise" [8] - The company was also listed in the top 10 for both responsible contribution and environmental contribution in the 2024 Green Light ESG Awards, being the only energy storage company to achieve this dual honor [8] - The carbon digital management platform received certification from TüV Rheinland, gaining industry-wide recognition for its effectiveness [8]

Financial Performance - Revenue reached RMB 9,420 million, a decrease of 726% year-over-year[6] - R&D expense was RMB 737 million, down 1110% year-over-year[7] - Net profit attributable to shareholders was RMB 765 million, an increase of 2542% year-over-year[8] - Net operating cash flow increased to RMB 1,056 million, up 1508% year-over-year[7] - 2024 Pharma R&D expenditure was RMB 4,910 million, accounting for 1698% of Pharma revenue[61] Key Products & Pipelines Progress - Serplulimab Injection (PD-1) received EMA approval for ES-SCLC treatment[12] - Tenapanor Hydrochloride Tablets approved by NMPA for serum phosphorus control in adult dialysis patients with chronic kidney disease[13] - Fosun Pharma achieved a revenue of RMB 11,297 million (+893% YoY) from countries and regions outside Chinese mainland in 2024[26] Med Tech Segment - Med Tech segment revenue reached RMB 4,390 million[87] - Sisram Medical's revenue was USD 3590 million in 2024[96] Healthcare Services - Healthcare Services segment revenue was RMB 6,672 million[108] Sinopharm Performance - Pharmaceutical distribution segment revenue recorded RMB 444,365 million (+075% YoY)[116] - Medical device distribution segment revenue recorded RMB 117,915 million (-944% YoY)[116] - Revenue of the retail pharmacy segment recorded RMB 35,981 million (+082% YoY)[116]

Core Points - The Shanghai First Pharmaceutical Co., Ltd. will hold its 2024 Annual General Meeting on June 20, 2025, with both on-site and online voting options available for shareholders [1][2][3] - The meeting will cover 12 proposals, including the annual report, board and supervisory reports, financial statements, and various governance matters [6][7][15] - The company emphasizes maintaining shareholder rights and ensuring orderly conduct during the meeting [4][5] Meeting Agenda - The meeting will start with attendance reporting and the announcement of the meeting's commencement [1] - Proposals will be read and discussed, followed by independent directors' reports and shareholder Q&A sessions [1][3] - Voting will occur after discussions, with results announced by the legal representative [1][6] Voting Procedures - Shareholders must present valid identification and may appoint proxies with proper authorization to vote [2][4] - Voting will be conducted through both on-site and online methods, with specific time frames for each [4][5] - Each proposal will be voted on individually, and any invalid votes will be counted as abstentions [5][6] Board and Supervisory Reports - The board's report will detail the company's operations and governance practices, highlighting compliance with legal and regulatory requirements [7][8][10] - The supervisory report will confirm the company's adherence to laws and regulations, ensuring the protection of shareholder interests [15][17] Financial Overview - The financial report for 2024 will be presented, including audited financial statements and budget proposals for 2025 [22] - The company has received a standard unqualified audit opinion from its accounting firm [22]

Group 1: Company Strategy and Development - The company focuses on health sectors, particularly cardiovascular, digestive, analgesic, and anesthetic medications, aiming to enhance its formulation industry and maintain its unique drug formulations and controlled-release technologies [3][6]. - Plans to accelerate the development and market entry of high-barrier generics and innovative drugs while expanding its international business through a global formulation production platform [3][6]. - The company aims to build a high-end active pharmaceutical ingredient (API) and intermediate manufacturing base with a focus on green and intelligent manufacturing technologies [4][6]. Group 2: Financial Performance and Challenges - The company experienced a significant decline in revenue in 2024, primarily due to national procurement policies leading to a substantial drop in sales prices of key formulation products [5][7]. - The decline in revenue was also influenced by competitive pressures in the domestic and international markets affecting the sales prices of major API products [5][7]. - Cumulative cash dividends since the company's listing in 2018 have reached CNY 496 million, reflecting a commitment to shareholder returns [8]. Group 3: Market Expansion and Partnerships - The company has successfully obtained market access qualifications for certain specialty APIs in major markets, including the WHO, the USA, the EU, and Japan, and is actively exploring emerging markets in the Middle East, South Asia, Southeast Asia, and South America [4][6]. - Established long-term stable partnerships with numerous large formulation manufacturers, positioning itself as a leading supplier of antihypertensive APIs globally [4][6]. Group 4: Research and Development Focus - The company continues to focus on both innovative and generic drug development, with recent submissions for new drug applications and multiple product registrations for generics [9]. - Future R&D efforts will concentrate on health-related fields, leveraging core technological advantages in controlled-release formulations and APIs [9].

Core Viewpoint - The company held its 2024 annual performance briefing on May 27, 2025, focusing on investor engagement and addressing key concerns regarding its market strategies and financial performance [1]. Group 1: Company Performance and Financials - In 2024, the company reported a revenue of 2.591 billion yuan, a decrease of 785 million yuan year-on-year, but a growth of 4.53% when excluding certain impacts [4]. - The net cash flow from operating activities was 291 million yuan, down 37.40% from the adjusted figure of 464 million yuan, primarily due to changes in payment collection timing and accounts payable [4]. - Despite a decline in revenue, the net profit increased by nearly 30%, driven by non-recurring gains and cost optimization efforts [8]. Group 2: Market Strategies and Initiatives - The company is actively implementing a "quality improvement, efficiency enhancement, and return to shareholders" strategy, focusing on transparent investor relations and ESG governance [2]. - The company has initiated its first ESG report, emphasizing sustainable development and a three-tier governance structure for effective ESG implementation [2]. - The acquisition of Qingyang Xingrui Energy, which represents a strategic move in the northwest LNG market, aims to enhance market share and operational efficiency [5]. Group 3: Future Outlook and Innovations - The company is committed to advancing its digital transformation in the gas sector, focusing on safety operations and efficiency upgrades through technological innovation [5]. - The company is exploring opportunities in the AIDC sector, anticipating increased electricity demand and positioning itself to provide integrated energy services [10]. - Future plans include enhancing green and low-carbon initiatives, focusing on the efficient use of natural gas and renewable energy integration [10].

Group 1: Financial Management and Cash Flow - The company adopts a prudent cash flow management strategy to ensure safety amidst high capital expenditures in the industry, including controlling capital expenditure scale and optimizing profit structure [2] - Future plans for issuing bonds or policy loans will depend on specific circumstances [2] - The company has seen a significant increase in gross margin in Q1, primarily driven by gas sales growth and timely price linkage [3] Group 2: Market Position and Competition - The company maintains a competitive advantage in Shaanxi Province due to its infrastructure and service capabilities, despite pressure from leading companies expanding into the region [3] - The company is exploring opportunities for regional integration and collaboration with new energy and power grid companies to strengthen its competitive position [3] Group 3: Project Management and Future Planning - The delay in the construction of the Shenmu LNG emergency peak-shaving station project was based on a comprehensive assessment of industry trends and regional resource supply [4] - The company is focused on strategic layout for new business areas, such as smart integrated energy services, which are still in the cultivation phase and expected to have limited impact on overall performance in the short term [4] Group 4: Risk Management and Internal Controls - The company has established a robust internal control system focused on compliance and risk prevention, continuously optimizing governance efficiency [4] - The effectiveness of internal controls is influenced by execution strength and external environmental changes, and the company will maintain dynamic supervision mechanisms [4] Group 5: ESG and Sustainable Development - The company has developed a comprehensive ESG governance system and released its 2024 Social Responsibility Report, detailing initiatives in emissions reduction, tax contributions, and employee development [6] - The company emphasizes sustainable high-quality development and resource integration to maintain market competitiveness [6] Group 6: Pricing and Market Dynamics - The company has established a basic price transmission mechanism in response to international gas price fluctuations and domestic pricing policy adjustments [6] - The company’s operating area has implemented a "gate station price + distribution fee" linkage mechanism, although there are delays in price transmission in some regions due to local government considerations [6] Group 7: Shareholder Relations and Value Management - The company is committed to balancing short-term shareholder returns with long-term development funding needs through its dividend policy [6] - Future stock buyback shares will be used for equity incentives or employee stock ownership plans, with specific plans under active research [6]

Group 1 - The event titled "China-Switzerland Financial Institutions Technology Finance High-Level Exchange Conference" was held in Shanghai, focusing on deepening financial cooperation between China and Switzerland to support the construction of Shanghai as an international financial center [1][10] - The conference featured over 20 high-level executives from both countries, including representatives from financial institutions and universities, highlighting the importance of collaboration in the financial sector [2][3] Group 2 - Discussions centered on financial openness, technology investment, and green transformation, with emphasis on China's growing market potential and the opportunities for foreign investment in green bonds and ESG [6][10] - Swiss representatives expressed interest in China's innovations in open-source models and digital payments, discussing the application of digital currency in international payments and the importance of ESG governance in technology industries [7][10] Group 3 - The conference concluded with a call for the establishment of platforms to enhance understanding of Chinese listed companies among Swiss investors, aiming to improve the connectivity of stock markets between China and Switzerland [8][10] - The event aimed to foster regional economic development and promote bilateral financial cooperation, with a focus on creating a high-quality business environment for foreign investment in China [10]

Financial Performance - Guizhou Moutai achieved a revenue growth of 15.71%, reaching 170.9 billion yuan, with a net profit increase of 15.38% to 86.2 billion yuan, surpassing set targets [1] - The net cash flow from operating activities surged by 38.85% to 92.5 billion yuan, supporting total assets exceeding 298.9 billion yuan and maintaining a return on equity above 30% for eight consecutive years [1] - High-end liquor sales generated 145.9 billion yuan, growing by 15.28%, while the sauce-flavored liquor series surpassed 24.6 billion yuan with a growth rate of 19.65%, indicating a dual-driven growth model [1] Strategic Insights - The management addressed shareholder concerns regarding industry cycles by highlighting the "three-phase overlap" theory, which includes macroeconomic transitions, industry adjustments, and Moutai's brand positioning [2] - The company maintains strategic stability through three basic supports: the positive trend of the Chinese economy, brand value recognition, and product scarcity [2] Shareholder Returns - Moutai reported a record cash dividend of 64.7 billion yuan, with a total distribution rate exceeding 80% when including share buybacks [3] - The company initiated its first-ever share buyback, acquiring 2.0175 million shares at a maximum price of 1584.06 yuan per share, reflecting confidence in its development [3] - Moutai's dividend yield continues to lead among A-share blue-chip companies, showcasing its commitment to shareholder value [3] ESG Governance - Moutai has integrated "ecological priority" into its development strategy, achieving 100% compliance in wastewater discharge for five consecutive years and covering 85% of its green factory certification [6] - The company has increased its investment in rural revitalization by 22% and established a 1 billion yuan education fund, demonstrating a commitment to social responsibility [6] - Moutai's governance model has improved decision-making efficiency by 30% through a strategic-budget-assessment management system [7] Cultural Foundation - Moutai emphasizes its cultural roots, tracing back to its founding principles and integrating traditional values with modern concepts [8] - The company maintains a quality control network with 365 control points and over 2000 technical standards, ensuring a 100% product pass rate [8] Future Development - Moutai's management outlined a clear development blueprint focusing on market adaptation in the short term, internationalization and youth engagement in the mid-term, and building a shared ecosystem in the long term [9] - The company plans to increase R&D investment intensity to 3.5%, targeting advancements in microbial strain libraries and intelligent brewing equipment [9] - Moutai aims to become a world-class listed company, contributing to global supply chains and participating in international standard-setting [9]